Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · IEX Real-Time Price · USD
11.01
+0.50 (4.81%)
At close: Jul 19, 2024, 4:00 PM
12.97
+1.96 (17.80%)
Pre-market: Jul 22, 2024, 7:11 AM EDT
Atara Biotherapeutics Stock Forecast
ATRA's stock price has decreased by -79.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ATRA stock have an average target of 150.7, with a low estimate of 11 and a high estimate of 625. The average target predicts an increase of 1,268.76% from the current stock price of 11.01.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for ATRA stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 8 | 8 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $13 → $11 | Strong Sell | Maintains | $13 → $11 | -0.09% | Jul 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 22, 2024 |
| Stifel | Stifel | Hold Maintains $120 → $58 | Hold | Maintains | $120 → $58 | +422.25% | Apr 1, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $75 → $13 | Strong Sell | Maintains | $75 → $13 | +13.53% | Nov 10, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2023 |
Financial Forecast
Revenue This Year
113.21M
from 8.57M
Increased by 1,220.54%
Revenue Next Year
72.90M
from 113.21M
Decreased by -35.61%
EPS This Year
-0.66
from -65.25
EPS Next Year
-0.67
from -0.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 156.9M | 161.1M | 153.4M | 350.0M | 157.5M |
| Avg | 113.2M | 72.9M | 96.1M | 228.7M | 153.0M |
| Low | 75.4M | 15.7M | 66.8M | 112.7M | 147.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1,730.2% | 42.3% | 110.4% | 264.0% | -31.1% |
| Avg | 1,220.5% | -35.6% | 31.9% | 137.8% | -33.1% |
| Low | 779.1% | -86.1% | -8.3% | 17.2% | -35.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.48 | 0.17 | -0.47 | 0.33 | -0.16 |
| Avg | -0.66 | -0.67 | -0.69 | 0.03 | -0.15 |
| Low | -0.80 | -1.23 | -1.02 | -0.25 | -0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.